共 16 条
[1]
DAMICO AV, 1993, CANCER-AM CANCER SOC, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO
[2]
2-N
[3]
Egawa S, 1999, CANCER, V86, P463
[4]
FRANKS LM, 1973, CANCER, V32, P1092, DOI 10.1002/1097-0142(197311)32:5<1092::AID-CNCR2820320513>3.0.CO
[5]
2-Z
[8]
Pretreatment prostate-specific antigen doubling times: Clinical utility of this predictor of prostate cancer behavior
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1996, 34 (03)
:549-553
[9]
LATENT PROSTATIC-CANCER IN A CONSECUTIVE AUTOPSY SERIES
[J].
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY,
1980, 14 (01)
:29-35
[10]
OBSERVATIONS OF PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME IN 107 PATIENTS REFERRED FOR DEFINITIVE RADIOTHERAPY
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1995, 31 (01)
:21-24